NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
GH Research PLC Ordinary Shares (NASDAQ: GHRS)
GHRS Technical Analysis
5
As on 9th Jun 2023 GHRS STOCK Price closed @ 12.24 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 14.32 & Strong Sell for SHORT-TERM with Stoploss of 19.10 we also expect STOCK to react on Following IMPORTANT LEVELS. |
GHRSSTOCK Price
Open | 12.50 | Change | Price | % |
High | 12.85 | 1 Day | -0.50 | -3.92 |
Low | 11.94 | 1 Week | 1.24 | 11.27 |
Close | 12.24 | 1 Month | 4.34 | 54.94 |
Volume | 36940 | 1 Year | -12.61 | -50.74 |
52 Week High 25.48 | 52 Week Low 6.02 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
GHRS Daily Charts |
GHRS Intraday Charts |
Whats New @ Bazaartrend |
GHRS Free Analysis |
|
GHRS Important Levels Intraday
RESISTANCE | 13.99 |
RESISTANCE | 13.43 |
RESISTANCE | 13.08 |
RESISTANCE | 12.74 |
SUPPORT | 11.74 |
SUPPORT | 11.40 |
SUPPORT | 11.05 |
SUPPORT | 10.49 |
GHRS Forecast April 2024
4th UP Forecast | 27.62 |
3rd UP Forecast | 22.69 |
2nd UP Forecast | 19.64 |
1st UP Forecast | 16.59 |
1st DOWN Forecast | 7.89 |
2nd DOWN Forecast | 4.84 |
3rd DOWN Forecast | 1.79 |
4th DOWN Forecast | -3.14 |
GHRS Weekly Forecast
4th UP Forecast | 21.39 |
3rd UP Forecast | 18.46 |
2nd UP Forecast | 16.64 |
1st UP Forecast | 14.83 |
1st DOWN Forecast | 9.65 |
2nd DOWN Forecast | 7.84 |
3rd DOWN Forecast | 6.02 |
4th DOWN Forecast | 3.09 |
GHRS Forecast2024
4th UP Forecast | 52.38 |
3rd UP Forecast | 39.51 |
2nd UP Forecast | 31.55 |
1st UP Forecast | 23.59 |
1st DOWN Forecast | 0.89 |
2nd DOWN Forecast | -7.07 |
3rd DOWN Forecast | -15.03 |
4th DOWN Forecast | -27.9 |
GH Research PLC Ordinary Shares ( NASDAQ USA Symbol : GHRS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
GHRS Other Details
Segment | EQ | |
Market Capital | 1342136576.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
GHRS Address
GHRS Latest News
GHRS Business Profile
GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable 5-MeO-DMT product candidate that is being investigated in the Phase 2 part of an ongoing Phase 1/2 clinical trial in patients with TRD. The company also develops GH002, an injectable 5-MeO-DMT product candidate that is in preclinical development trials with a focus on psychiatric and neurological disorders. GH Research PLC was founded in 2018 and is based in Dublin, Ireland. Address: 28 Baggot Street Lower, Dublin, Ireland, D02 NX43
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service